Table 2.
Recurrence characteristics based on stage of diseases
| Stages | Number of patients | Mean DFI (±SD) months | Group 1 (recurrence symptom in local site) (%) | Group 2 (pelvic recurrence site) (%) | Group 3 (metastases to far organs) (%) | Group 4 (complex recurrence) (%) | Major presenting symptoms (%) | Parametrium involvement | Lymph node involvement | Marginal vagina involvement |
|---|---|---|---|---|---|---|---|---|---|---|
| IA1 | 1 | 36 | 1 (100) | Abdominal pain (100) | 1 | |||||
| IB1 | 9 | 32.2 (±10.7) | 6 (66.7) | 2 (22.2) | 1 (11.1) | Vaginal bleeding (55.6) | 1 | 3 | ||
| IB2 | 1 | 8 | 1 (100) | Vaginal bleeding (100) | 1 | |||||
| IIA | 8 | 8.0 (±4.3) | 5 (62.5) | 1 (12.5) | 1 (12.5) | 1 (12.5) | Vaginal bleeding (100) | 1 | 1 | |
| IIB | 12 | 7.2 (±2.8) | 8 (66.7) | 2 (16.7) | 2 (16.7) | Vaginal bleeding (58.3) | 2 | 1 | 3 | |
| IIIA | 3 | 33.4 (±116) | 2 (66.7) | 1 (33.3) | Vaginal bleeding, abdominal pain and weight loss (33.3) | |||||
| IIIB | 1 | 13 | 1 (100) | Abdominal pain (100) | 1 | 1 | ||||
| IV | 1 | 12 | 1 (100) | Vaginal bleeding (100) | ||||||
| Total | 36 | 27.5 (±13.6) | 23 (63.9) | 4 (11.1) | 5 (13.9) | 4 (11.1) | Vaginal bleeding (52.8) | 4 | 4 | 8 |